Work

PHASE II evaluation of dalantercept for persistent or recurrent epithelial ovarian and related cancers: An NRG oncology study.

Year: 2016

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2016.34.15_suppl.e17050

Authors: Robert Allen Burger, Wei Deng, Vicky Makker, Heather A. Lankes, Carol Aghajanian, Heidi J. Gray, James Lloyd Wade, Steven E. Waggoner, Douglas A. Levine

Institutions: University of Pennsylvania, Memorial Sloan Kettering Cancer Center, Gynecologic Oncology Group, University of Washington, University Hospitals of Cleveland

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2891481297

Cites:

Cited by: 2

Related to: 10